4//SEC Filing
Tester Jason E. 4
Accession 0001209191-21-041713
CIK 0001819790other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 7:26 PM ET
Size
7.9 KB
Accession
0001209191-21-041713
Insider Transaction Report
Form 4
Tester Jason E.
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2021-06-15+10,000→ 10,000 totalExercise: $35.26Exp: 2031-06-15→ Common Stock (10,000 underlying) - Award
Stock Option (right to buy)
2021-06-15+10,000→ 10,000 totalExercise: $35.26Exp: 2031-06-15→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2021 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- [F2]Option granted in connection with the Reporting Person's service as a non-employee director as of the closing of the Company's initial public offering and continued service as of the Company's 2021 annual meeting of stockholders. The option is fully vested.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001827272
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 7:26 PM ET
- Size
- 7.9 KB